|
Senior Member
|
https://www.medrxiv.org/content/10....102v3.full-text
引用:
8,837 vaccinated participants (median age 65 years [IQR: 58, 71]), contributed 17,160 samples (10,508 following ChAdOx1, 6,547 following BNT162b2). Seropositivity to Spike was 96.79% (95% CI 96.42, 97.12) from 28 days following a single dose, reaching 99.34% (98.91, 99.60) from 14 days after a second dose.
|
https://www.medrxiv.org/content/10....102v1.full-text
引用:
8,517 vaccinated participants (median age 65 years [IQR: 58, 71]), contributed 13,232 samples (8,115 following ChAdOx1, 5,008 following BNT162b2). Seropositivity to Spike was 96.42% (95%CI 96, 96.79) at 28-34 days following a single dose, reaching 99.08% (97.8, 99.62) at 7-14 days after a second dose
|
這是BNT跟AZ施打第一劑跟第二劑後血清陽轉率數據
平均都是在99%以上
median age 65 years
|